肝细胞癌癌前病变诊断和治疗多学科专家共识(2023版)  

Multidisciplinary experts consensus on diagnosis and treatment of precancerous lesions of hepatocellular carcinoma(2023 version)

作　　者：中华医学会肝病学分会肝癌学组 中华肝脏病杂志编辑委员会 夏锋 张大志[3] 李雪松 蒋涵羽 康娟 高沿航[6] 王玉婷 何泰瑜 Liver Cancer Study Group,Chinese Society of Hepatology,Chinese Medical Association;Editorial Board of Chinese Journal of Hepatology;Xia Feng;Zhang Dazhi(不详;Department of Hepatobiliary Surgery,the First Hospital Affiliated to Army Military Medical University(Southwest Hospital),Chongqing,400038,China;Department of Infecious Disease,the Second Affiliated Hospital of Chongqing Medical University,Chongqing 400010,China)

机构地区：[1]不详 [2]陆军军医大学第一附属医院肝胆外科,重庆400038 [3]重庆医科大学附属第二医院感染病科,重庆400010 [4]四川大学华西医院 [5]重庆医科大学附属第二医院 [6]吉林大学第一医院

出　　处：《中华肝脏病杂志》2023年第12期1250-1261,共12页Chinese Journal of Hepatology

基　　金：重庆市自然科学基金面上项目(CSTB2023NSCQ-MSX0563)。

摘　　要：根据最新的统计数据,我国的肝癌发病率和病死率呈上升趋势,已成为国人健康的重大威胁。肝癌的发生与肝内癌前病变的形成密切相关,肝癌癌前病变的相关临床及基础研究发展较快,诊断和治疗的理念和具体技术方法也随之有了新的变化和进展。因此,本共识在2020年第一版的基础上,组织多学科专家,结合各自专业领域国内外的最新进展,加以整理并完善拟订出新的版本,以提升临床医师对肝癌癌前病变的认识,规范其病理学、影像学及分子诊断标准,拓宽早期筛查的方法、制定科学合理的治疗方案,为促进肝癌诊疗策略的前移和整体提升肝癌患者的5年总生存率提供帮助。According to the latest statistical data,the incidence and mortality rate of hepatocellular carcinoma in China are still on the rise,posing a major threat to the health of the Chinese population.The occurrence is closely related to the formation of precancerous lesions in the liver.The clinical and basic research on precancerous lesions of hepatocellular carcinoma has developed rapidly,and the concepts and specific techniques for diagnosis and treatment have also undergone new changes and advancements.Therefore,based on the first version in 2020,this consensus has organized multidisciplinary experts to compile and improve a new version by integrating the latest progress in their respective professional fields at home and abroad.It aims to enhance clinicians'understanding of precancerous lesions of hepatocellular carcinoma standardize the pathology,imaging,and molecular diagnostic criteria,broaden early screening methods,formulate scientifically rational treatment plans,and help promote the advancement of diagnosis and treatment strategies and to enhance the overall 5-year survival rate of patients with hepatocellular carcinoma.

关 键 词：肝细胞癌 癌前病变 诊断 治疗 多学科协作组 共识 

分 类 号：R735.7[医药卫生—肿瘤]